The role of the immune system in hexachlorobenzene-induced toxicity

Environmental Health Perspectives

Volumn 107, Issue SUPPL. 5, 1999, Pages 783-792

  Michielsen, Carola C P P C ^a   Van Loveren, Henk ^b   Vos, Joseph G ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Autoantibodies; Hexachlorobenzene; Immunopathology; Immunotoxicity; Lung; Rat; Skin

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; ENVIRONMENTAL CHEMICAL; FUNGICIDE; HEXACHLOROBENZENE; IMMUNOGLOBULIN M ANTIBODY;

ALLERGIC REACTION; ANTIBODY TITER; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; CONFERENCE PAPER; EXPERIMENTAL MODEL; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOTOXICITY; INTOXICATION; LUNG INJURY; LYMPH NODE; METABOLISM; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; SKIN DEFECT; SPLEEN WEIGHT; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION; THYMUS; TURKEY (REPUBLIC);

ANIMALIA; RATTUS NORVEGICUS;

EID: 0032700436     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.99107s5783     Document Type: Conference Paper

References (95)

1. U.S. EPA. Survey of Industrial Processing Data. Task I: Hexachlorobenzene and Hexachlorobutadiene Pollution from Chlorocarbon Processes. EPA 560/3-75-003. Washington, DC: U.S. Environmental Protection Agency, 1975.
2. Jacoff FS, Scarberry B. Source assessment of hexachlorobenzene from the organic chemical manufacturing industry. In: Hexachlorobenzene: Proceedings of an International Symposium (Morris CR, Cabral JRP, eds). IARC Sci Publ 77:31-37 (1986).
3. Mill T, Haag W. The environmental fate of hexachlorobenzene. In: Hexachlorobenzene: Proceedings of an International Symposium (Morris CR, Cabral JRP, eds). IARC Sci Publ 77:61-66 (1986).
4. Mansour M, Scheunert R, Viswanathan R. Korte F. Assessment of the persistence of hexachlolobenzene in the ecosphere. In: Hexachlorobenzene: Proceedings of an International Symposium (Morris CR, Cabral JRP, eds). IARC Sci Publ 77:53-59 (1986).
5. Uhnák J, Veningeróva M, Madaric A. Dynamics of hexachlorobenzene residues in the food chain. In: Hexachlorobenzene: Proceedings of an International Symposium (Morris CR, Cabral JRP, eds). IARC Sci Publ 77:109-113 (1986).
6. Braune BM, Norstrom RJ. Dynamics of organochlorine compounds in herring gulls. III: Tissue distribution and bioaccumulation in Lake Ontario gulls. Environ Toxicol Chem 8:957-968 (1989).
7. Vos JG, Breeman HA, Benschop H. The occurrence of the fungicide hexachlorobenzene in wild birds and its toxicological importance: a preliminary examination. Meded Rijksfac Lanbouwwet Rijksuniv Gent 33:1263-1269 (1968).
8. Peters HA, Johnson SAM, Cam S, Oral S, Müftü Y, Ergene T. Hexachlorobenzene-induced porphyria: effect of chelation on the disease, porphyrin and metal metabolism. Am J Med Sci 251:314-322 (1966).
9. Needham LL, Burse VW, Head SL, Korver MP, McClure PC, Andrews JS Jr, Rowley DL, Sung J, Kahn SE. Adipose tissue/serum partitioning of chlorinated hydrocarbon pesticides in humans. Chemosphere 20:975-980 (1990).
10. Camps M, Planas J, Gómez-Catalán J, Sabroso M, To-Figueras J, Corbella J. Organochlorine residues in human adipose tissue in Spain: study of an agrarian area. Bull Environ Contam Toxicol 42:195-201 (1989).
11. U.S. EPA. Hexachlorobenzene Health Advisory. Washington, DC:U.S. Environmental Protection Agency, 1987.
12. WHO. IPCS Environmental Health Criteria for Hexachlorobenzene. No 195. Geneva:World Health Organization, 1997.
13. U.S. EPA. Health Assessment Document for Chlorinated Benzenes. EPA 600/8-84-015F. Washington, DC:U. S. Environmental Protection Agency, 1985.
14. Rozman K, Rozman T, Greim H. Enhanced fecal elimination of stored hexachlorobenzene from rats and rhesus monkeys by hexadecane or mineral oil. Toxicology 22:33-44 (1981).
15. Koss G, Koransky W, Steinbach K. Studies on the toxicity of hexachlorobenzene. II: Identification and determination of metabolites. Arch Toxicol 35:107-114 (1976).
16. Koss G, Seubert S, Seubert A, Koransky W, Ippen H. Studies on the toxicology of hexachlorobenzene. III: Observations in a longterm expriment. Arch Toxicol 40:285-294 (1978).
17. Koss G, Reuter A, Koransky W. Excretion of metabolites of hexachlorobenzene in the rat and in man. In: Hexachlorobenzene: Proceedings of an International Symposium (Morris CR, Cabral JRP, eds). IARC Sci Publ 77:261-266 (1986).
18. Renner G, Richter E, Schuster KP. N-Acetyl-S-(pentachlorophenyl)-cysteine, a new urinary metabolite of hexachlorobenzene. Chemosphere 8:663 (1978).
19. Renner G. Biotransformation of the fungicides hexachlorobenzene and pentachloronitrobenzene (PCNB). Xenobiotica 11:534-446 (1981).
20. Van Ommen B, Hendriks W, Bessems JGM, Geesink G, Müller F, Van Bladeren PJ. The relation between the oxidative biotransformation of hexachlorobenzene and its porphyrinogenic activity. Toxicol Appl Pharmacol 100:517-528 (1989).
21. Elder GH, Evans JO, Matlin SA. The effect of the porphyrogenic compound, hexachlorobenzene, on the activity of hepatic uroporphyrinogen decarboxylase in the rat. Clin Sci Mol Med 51:71-80 (1976).
22. San Martin de Viale LC, Rios de Molina, M del C, Wainstok de Calmanovici R, Tomio JM. Experimental porphyria induced in rats by hexachlorobenzene. In: Porphyrins in Human Diseases (Doss M, ed). Basal:Kargel, 1976:445-452.
23. Ockner RK, Schmid R. Acquired porphyria in man and rat due to hexachlorobenzene intoxication. Nature (Lond) 189:499 (1961).
24. De Matteis F, Prior BE, Rimington C. Nervous and biochemical disturbances following hexachlorobenzene intoxication. Nature 191 (4786):363-366 (1961).
25. Vos JG, Van der Maas HL, Musch A, Ram E. Toxicity of hexachlorobenzene in Japanese quail with special reference to porphyria, liver damage, reproduction and tissue residues. Toxicol Appl Pharmacol 18:944-957 (1971).
26. Strik JJTWA, Wit JG. Hepatic porphyria in birds and mammals. TNO nieuws 27:604-610 (1972).
27. Smith AG, Cabral JR. Liver-cell tumors in rats fed hexachlorobenzene. Cancer Lett 11:169-172 (1980).
28. Cabral JRP, Mollner T, Raitano F, Shubik P. Carcinogenesis of hexachlorobenzene in mice. Int J Cancer 23:47-51 (1979).
29. Cabral JRP, Shubik P. Carcinogenic activity of hexachlorobenzene in mice and hamsters. In: Hexachlorobenzene: Proceedings of an International Symposium (Morris CR, Cabral JRP, eds). IARC Sci Publ 77:411-416 (1986).
30. Lambrecht RW, Ertork E, Grunden EE, Peters HA, Morris CR, Bryan GT. Renal tumours in rats chronically exposed to hexachlorobenzene (HCB) [Abstract]. Proc Am Assoc Cancer Res 24:59 (1983).
31. Cabral JRP, Shubik P, Mollner T, Raitano F. Carcinogenicity of hexachlorobenzene in hamsters. Nature 269:510-511 (1977).
32. Stewart FP, Manson MM, Cabral JRP, Smith AG. Hexachlorobenzene as a promoter of diethylnitrosamine-initiated hepatocarcinogenesis in rats and comparison with induction of porphyria.Carcinogenesis 10(7):1225-1230 (1989).
33. Carthew P, Smith AG. Pathological mechanisms of hepatic tumour formation in rats exposed chronically to dietary hexachlorobenzene. J Appl Toxicol 14:447-452 (1994).
34. Grimalt JO, Sunyer J, Moreno V, Amaral OC, Scala M, Rosell A, Anto JM, Albaiges J. Risk excess of soft-tissue and thyroid cancers in a community exposed to airborne organochlorinated compound mixtures with a high hexachlorobenzene content. Int J Cancer 56:200-203 (1994).
35. IARC. Hexachlorobenzene. In: Overall Evaluations of Carcinogenicity. An Updating of IARC Monographs, Volumes 1 to 42, IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Supplement 7, Lyon:International Agency for Research on Cancer, 1987;219-220.
36. Iatropolous MJ, Hobson W, Knauf V, Adams HP. Morphological effects of hexachlorobenzene toxicity in female rhesus monkeys. Toxcicol Appl Pharmacol 37:433-444 (1976).
37. Jarrell JF, McMahon A, Villeneuve D, Franklin C, Singh A, Valli VE, Bartlett S. Hexachlorobenzene toxicity in the monkey primordial germ cell without induced porphyria. Reprod Toxicol 7:41-47 (1993).
38. Foster WG, Pentick JA, McMahon A, Lecavalier PR. Ovarian toxicity of hexachlorobenzene (HCB) in the superovulated female rat J Biochem Toxicol 7:1-4 (1992).
39. Foster WG, Mertineit C, Yagminas A, McMahon A, Lecavalier PR. The effects of hexachlorobenzene on circulating levels of adrenal steroids in the ovariectomized rat. J Biochem Toxicol 10(3):129-135 (1995).
40. Den Tonkelaar EM, Verschueren HG, Bankovska J, De Vries T, Kroes R, Van Esch G. Hexachlorobenzene toxicity in pigs. Toxicol Appl Pharmacol 43:137-145 (1978).
41. Simon GS, Tardiff RG, Borzelleca JF. Failure of hexachlorobenzene to induce dominant lethal mutations in the rat. Toxicol Appl Pharmacol 47:415-419 (1979).
42. Grant DL, Phillips WEJ, Hatina GV. Effect of hexachlorobenzene on reproduction in the rat. Arch Environ Contam Toxicol 5:207-216 (1977).
43. Rush GF, Smith JH, Malta K, Bleavins M, Aulerich RJ, Ringer RK, Hook JB. Perinatal hexachlorobenzene toxicity in the mink. Environ Res 31:116-124 (1983).
44. Bleavins MR, Aulerich RJ, Ringer RK. Effects of chronic dietary hexachlorobenzene exposure on the reproductive performance and survivability of mink and European ferrets. Arch Environ Contam Toxicol 13:357-365 (1984).
45. Jarrell J, Gocmen A, Foster W, Brant R, Chan S, Sevcik M. Evaluation of reproductive outcomes in women inadvertently exposed to hexachlorobenzene in southeastern Turkey in the 1950s. Reprod Toxicol 12(4):469-476 (1998).
46. Courtney KD. Hexachlorobenzene (HCB): a review. Environ Res 20:225-266 (1979).
47. Gajdos A, Gajdos-Torok BM. Porphyrie experimentale observee chez le rat blanc a la suite de l'intoxication par l'hexachlorobenzene. Rev Fr Etud Clin Biol 6:549-552 (1961).
48. Campbell JAH. Pathological aspects of hexachlorobenzene feeding in rats. S Afr J Lab Clin Med 9203-206 (1963).
49. Kuiper-Goodman T, Grant DL, Moodle CA, Korsrud GO, Munro IC. Subacute toxicity of hexachlorobenzene in the rat. Toxicol Appl Pharmacol 40:529-549 (1977).
50. Cam C. Cases of skin porphyria related to hexachlorobenzene intoxication. Saglik Dergisi 32:215-216 (1958).
51. Cam C. Une nouvelle dermatose épidémique des enfants. Ann Dermatol 87:393-397 (1960).
52. Bickers DR. The dermatological manifestations of human porphyria. Ann NY Acad Sci 514:261-267 (1997).
53. Dogramaci I, Wray JD, Ergene T, Sezer V, Müftü Y. Porphyria turcica: a survey of 592 cases of cutaneous porphyria seen in southeastern Turkey. Turk J Pediatr 4:133-148 (1962).
54. Dogramaci I. Porphyrias and porphyrin metabolism with special reference to porphyria in childhood. Adv Pediatr 13:11-63 (1964).
55. Dogramaci I, Kenanoglu A, Müftü Y, Ergene T, Wray JD. Bone and joint changes in patients with Porphyria turcica. Turkish J Pediat 4:149-156 (1962).
56. Peters HA, Gocmen A, Cripps DJ, Bryan GT, Dogramaci I. Epidemiology of hexachlorobenzene-induced porphyria in Turkey: clinical and laboratory follow-up after 25 years. Arch Neurol 39:744-749 (1982).
57. Cripps DJ, Peters HA, Gocmen A, Dogramaci I. Porphyria turcica due to hexachlorobenzene: a 20 to 30 year follow-up study on 204 patients. Br J Dermatol 111:413-422 (1984).
58. Guiding Principles in the Use of Animals in Toxicology (Adopted by the Society of Toxicology in July 1989). Statement printed in the January issue of Toxicology and Applied Pharmocology.
59. Vos JG, Van Logten MJ, Kreeftenberg JG, Kruizinga W. Hexachlorobenzene-induced stimulation of the humoral immune response in rats. Ann NY Acad Sci 320:535-550 (1979).
60. Vos JG, Van Logten MJ, Kreeftenberg JG, Steerenberg PA, Kruizinga W. Effect of hexachlorobenzene on the immune system of rats following pre-and postnatal exposure. Drug Chem Toxicol 2:61-67 (1979).
61. Schielen P, Schoo W, Tekstra J, Oostermeijer HHA, Seinen W, Bloksma N. Autoimmune effects of hexachlorobenzene in the rat. Toxicol Appl Pharmacol 122:233-243 (1993).
62. Schielen P, Den Besten C, Vos JG, Van Bladeren PJ, Seinen W, Bloksma N. Immune effects of hexachlorobenzene in the rat: role of metabolism in a 13-week feeding study. Toxicol Appl Pharmacol 131:37-43 (1995).
63. Vos JG, Brouwer GMJ, Van Leeuwen FXR, Wagenaar S. Toxicity of hexachlorobenzene in the rat following combined pre-and postnatal exposure: comparison of effects on immune system, liver and lung. In: Immunotoxicology (Parke DV, Gibson GG, Hubbard R, eds). London:Academic Press, 1983:219-235.
64. Sherwood RL, Thomas PT, O'Shea WJ, Bradof JN, Ratajczak HV, Graham JA, Aranyi C. Effects of inhaled hexachlorobenzene aerosols on rat pulmonary host defenses. Toxicol Ind Health 5:451-461 (1989).
65. Vandebriel RJ, Meredith C, Scott MP, Roholl PJM, Van Loveren H. Effects of in vivo exposure to bis(tri-n-butyltin)oxide, hexachlorobenzene, and benzo(a)pyrene on cytokine (receptor) mRNA levels in cultured rat splenocytes and on IL-2 receptor protein levels. Toxicol Appl Pharmacol 148(1):126-136 (1998).
66. Van Loveren H, Kranjc El, Rombout PJA, Blommaert FA, Vos JG. Effects of ozone, hexachlorobenzene, and bis(tri-n-butyltin)oxide on natural killer activity in the rat lung Toxicol Appl Pharmacol 102:21-33 (1990).
67. Vos JG, Dormans JAMA, Kraal G, Kranjc El, Kranjc-Franken MAM, Van Loveren H. Immunotoxicity of hexachlorobenzene is thymus-dependent [Abstract] Toxicologist 10:221 (1990).
68. Van Loveren H, Van Eden W, Kranjc El, Kranjc-Franken MAM, De Kort W, Vos JG. Hexachlorobenzene interferes with the development of experimental autoimmune diseases in the Lewis rat (Abstract). Toxicologist 10:221 (1990).
69. Huitinga I, Ruuls SR, Van Rooyen N, Hartung H-P, Dijkstra CD. Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats. Clin Exp Immunol 100:344-351 (1995).
70. Smith T, Hewson AK, Kingsley CI, Leonard JP, Cuzner ML. Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat. Am J Pathol 150 (6):1909-1917 (1997).
71. Santos LL, Morand EF, Hutchinson P, Boyce NW, Holdsworth SR. Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis. Clin Exp Immunol 107:248-253 (1997).
72. Michielsen CPPC, Bloksma N, Ultee A, Van Mil F, Vos JG. Hexachlorobenzene-induced immunomodulation and skin and lung lesions: A comparison between Brown Norway, Lewis, and Wistar rats. Toxitol Appl Pharmacol 144:12-26 (1997).
73. Hayakawa K, Hardy RR, Honda M, Herzenberg LA, Steinberg AD, Herzenberg LA. Lγ-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies Proc Natl Acad Sci USA 81:2494-2498 (1984).
74. Loose LD, Pittman KA, Benitz KF, Silkworth JB. Polychlorinated biphenyl and hexachlorobenzene induced humoral immunosuppression. J Reticuloendoth Soc 22:253-271 (1977).
75. Loose LD, Silkworth JB, Pittman KA, Benitz KF, Mueller W. Impaired host resistance to endotoxin and malaria in polychlorinated biphenyl-and hexachlorobenzene-treated mice. Infect Immun 20:30-35 (1978).
76. Loose LD, Silkworth JB, Charbonneau T, Blumenstock F. Environmental chemical-induced macrophage dysfunction. Environ Health Perspect 39:79-91 (1981).
77. Carthew P, Edwards RE, Smith AG. Immunotoxic effects of hexachlorobenzene on the pathogenesis of systemic, pneumonic and hepatic virus infections in the mouse. Hum Exp Toxicol 8:403-411 (1990).
78. Silkworth JB, Loose LD. Assessment of environmental contaminant-induced lymphocyte dysfunction. Environ Health Perspect 39:105-128 (1981).
79. Vos JG. Immunotoxicity of hexachlorobenzene. In: Hexachlorobenzene: Proceedings of an International Symposium (Morris CR, Cabral JRP, eds). IARC Sci Publ 77: 347-356 (1986).
80. Barnett JB, Barfield L, Walls R, Joyner R, Owens R, Soderberg LSF. The effect of in utero exposure to hexachlorobenzene on the developing immune response of BALB/c mice. Toxicol Lett 39:263-274 (1987).
81. Gralla EJ, Fleishmann RW, Luthra YK, Hagopian M, Baker JR, Esber H, Marcus W. Toxic effect of hexachlorobenzene after daily administration to beagle dogs for one year. Toxicol Appl Pharmacol 40:227-239 (1977).
82. Queiroz MLS, Bincoletto C, Perlingeiro RCR, Souza CA, Toledo H. Defective neutrophil function in workers occupationally exposed to hexachlorobenzene. Hum Exp Toxicol 16:322-326 (1997).
83. Queiroz MLS, Bincoletto C, Perlingeiro RCR, Quadras MR, Souza CA. Immunoglobulin levels in workers exposed to hexachlorobenzene. Hum Exp Toxicol 17:172-175 (1998).
84. Queiroz MLS, Quadros MR, Valadares MC, Silveira JP. Polymorphonuclear phagocytosis and killing in workers occupationally exposed to hexachlorobenzene. Immunopharmacol Immunotoxicol 20(3):447-454 (1998).
85. Den Besten C, Bennik MM, Bruggeman I, Schielen P, Kuper F, Brouwer A, Koeman JH, Vos JG, Van Bladeren PJ. The role of oxidative metabolism in hexachlorobenzene-induced porphyria and thyroid hormone homeostasis: a comparison with pentachlorobenzene in a 13-week feeding study. Toxicol Appl Pharmacol 119:181-194 (1993).
86. Michielsen CPPC, Bloksma N, Pieters R, Rietjens I, Vos JG. Involvement of the mercapturic acid pathway in the immunopathology of hexachlorobenzene (HCB) [Abstract]. Pharmacol Toxicol Suppl III:103 (1997).
87. Goldstein JA, Friesen M, Scotti TM, Hickman P, Hass JR, Bergman H. Assessment of the contribution of chlorinated dibenzo-p-dioxins and dibenzofurans to hexachlorobenzene-induced toxicity, porphyria, changes in mixed function oxygenases, and histopathological changes. Toxicol Appl Pharmacol 46:633-649 (1978).
88. Kitchin KT, Linder RE, Scotti TM, Walsh D, Curley AO, Svensgaard D. Offspring mortality and maternal lung pathology in female rats fed hexachlorobenzene. Toxicology 23:33-39 (1982).
89. Michielsen CPPC, Bloksma N, Klatter FA, Rozing J, Hoekman JHG, Roholl PJM, Vos JG. Induction of skin lesions by hexachlorobenzene in the BN rat is T-cell dependent [Abstract]. Toxicologist 42:268 (1998).
90. Bloksma N, Kubicka-Muranyi M, Schuppe HC, Gleichmann E, Gleichman H. Predictive immunotoxicological test systems: suit-ability of the popliteal lymph node assay in mice and rats. Crit Rev Toxicol 25(5):369-396 (1996).
91. Weltzien HU, Moulon C, Martin S, Padovan E, Hartman U, Kohler J. T cell immune responses to haptens. Structural models for allergic and autoimmune reactions. Toxicology 107:141-151 (1996).
92. Driscoll KE, Lindenschmidt RC, Mauer JK, Higgins JM, Ridder G. Pulmonary response to silica or titanium dioxide: Inflammatory cells, alveolar macrophage-derivad cytokines, and histopathology. Am J Respir Cell Mol Biol 2:381-390 (1990).
93. Hirji N, Lin TJ, Befus DA. A novel CD8 molecule expressed by alveolar and peritoneal macrophages stimulates nitric oxide production. J Immunol 158:1833-1840 (1997).
94. Hirji N, Lin TJ, Bissonnette E, Belosevic M, Befus AD. Mechanisms of macropahge stimulation through CD8: macrophage CD8α and CD8β induce nitric oxide production and associated killing of the parasite Leishmania major. J Immunol 160(12):6004-6011 (1998).
95. Weller PF. The immunobiology of eosinophils. In: Seminars in Medicine of the Beth Israel Hospital, Boston (Flier JS, ed). N Engl J Med 18:1110-1118 (1991).